Logan Ganzen
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
20
Citations
198
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2017
Logan Ganzen studies inherited retinal degeneration, particularly retinitis pigmentosa, using zebrafish as a model organism. Their work combines visual behavior testing, drug screening, and electrophysiology to identify potential treatments and understand how disease-causing mutations disrupt the retina's signaling cells (bipolar and photoreceptor cells). Much of the research focuses on repurposing FDA-approved drugs (such as carvedilol) as candidate therapies for vision loss.
Publication output was higher in 2017-2019 (2-5 papers/year) and has slowed over the last five years to roughly one publication per year, with a gap in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Zebrafish Functional Screening of FDA-Approved Drugs for Autosomal Dominant Retinitis Pigmentosa Caused by RHODOPSIN Q344X Mutation
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Retinoic Acid-Dependent Loss of Synaptic Output from Bipolar Cells Impairs Visual Information Processing in Inherited Retinal Degeneration
Journal of Neuroscience · 2024
- Retinal bipolar cells borrow excitability from amacrine cells to amplify spatial features in dim light
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Retinoic acid-dependent loss of synaptic output from bipolar cells impairs visual information processing in inherited retinal degeneration
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Referee report. For: Affordable and effective optokinetic response methods to assess visual acuity and contrast sensitivity in larval to juvenile zebrafish [version 2; peer review: 2 approved]
Faculty of 1000 Research Ltd · 2022
- Drug screening with zebrafish visual behavior identifies carvedilol as a potential treatment for an autosomal dominant form of retinitis pigmentosa
Scientific Reports · 2021
- Referee report. For: Affordable and effective optokinetic response methods to assess visual acuity and contrast sensitivity in larval to juvenile zebrafish [version 1; peer review: 1 approved with reservations]
Faculty of 1000 Research Ltd · 2021
- Drug Screening with Zebrafish Visual Behavior Identifies Carvedilol as a Potential Treatment for Retinitis Pigmentosa
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- Drug Screening Utilizing the Visual Motor Response of a Zebrafish Model of Retinitis Pigmentosa
Purdue e-Pubs (Purdue University) · 2020
- A critical evaluation of TRPA1-mediated locomotor behavior in zebrafish as a screening tool for novel anti-nociceptive drug discovery
Scientific Reports · 2019
- The FDA-approved drug Carvedilol improves vison and retinal morphology in a zebrafish model of retinitis pigmentosa
IBRO Reports · 2019
- The FDA-approved Drug Carvedilol Improves Vision and Retinal Morphology in a Zebrafish Model of Retinitis Pigmentosa
2019
- 2095 Drug screening and hit identification for night blindness with zebrafish
Journal of Clinical and Translational Science · 2018
- Drug Screening and Hit Identification for Retinitis Pigmentosa with Zebrafish
Investigative Ophthalmology & Visual Science · 2018
- A pharmacological model of TRPA1‐mediated nociception in zebrafish larvae for therapeutic discovery
The FASEB Journal · 2018
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Scientific Reports×2
- Investigative Ophthalmology & Visual Science×2
- Journal of Clinical and Translational Science×2
- Faculty of 1000 Research Ltd×2
- Yuk Fai Leung
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Kang-Chieh Huang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Sanae S. Imanishi
Biochemistry, Genetics and Molecular Biology · Indiana University
- Colin Klaus
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Shimpei Takita
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile